Intravitreal Bevacizumab for Treatment of Subfoveal Idiopathic Choroidal Neovascularization: Results of a 1-Year Prospective Trial
Authors:
- Han ZhangHZHan Zhang
- Zhe-Li LiuZLZhe-Li Liu
- Peng SunPSPeng Sun
- Feng GuFGFeng Gu
- 1 February 2012
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 153 (2) , 300-306.e1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisationBritish Journal of Ophthalmology, 2007
- Photodynamic Therapy in Young PatientsOphthalmic Surgery, Lasers and Imaging Retina, 2006
- VerteporfinDrugs & Aging, 2006
- Choroidal neovascularizationAmerican Journal of Ophthalmology, 2004
- Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularizationOphthalmology, 2003
- Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfinAmerican Journal of Ophthalmology, 2002
- The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of ageOphthalmology, 1998
- Etiology of Choroidal Neovascularization in Young PatientsOphthalmology, 1996
- The Natural History of Idiopathic Subfoveal Choroidal NeovascularizationOphthalmology, 1995
- Idiopathic Focal Subretinal NeovascularizationAmerican Journal of Ophthalmology, 1976